Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

ClinicalTrials.gov ID: NCT00081796

Public ClinicalTrials.gov record NCT00081796. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 12:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Phase III Study of RPR109881 IV Every 3 Weeks Versus Capecitabine (Xeloda) Tablets Twice Daily for 2 Weeks in 3-Week Cycles in Patients With Metastatic Breast Cancer Progressing After Taxanes and Anthracycline Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical trial is to determine if RPR109881 is a better treatment than capecitabine (Xeloda) for advanced breast cancer in patients that no longer benefit from docetaxel and/or paclitaxel.

Study identification

NCT ID
NCT00081796
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
438 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2004 (Type not available)
Primary completion
Sep 2006 (Actual)
Completion
Sep 2006 (Actual)
Last update posted
Aug 21, 2008

2004 – 2006

United States locations

U.S. sites
89
U.S. states
28
U.S. cities
82
Facility City State ZIP Site status
Not listed Birmingham Alabama 35216 —
Not listed Tucson Arizona 85704 —
Not listed Little Rock Arkansas 72205 —
Not listed Bakersfield California 93309 —
Not listed Burbank California 91505 —
Not listed Concord California 94520 —
Not listed Fountain Valley California 92708 —
Not listed Fresno California 93720 —
Not listed Fullerton California 92835 —
Not listed Gilroy California 95020 —
Not listed Long Beach California 90806 —
Not listed Los Angeles California 90095 —
Not listed Monterey Park California 91754 —
Not listed Northridge California 91328 —
Not listed Oxnard California 93030 —
Not listed Pomona California 91767 —
Not listed Porterville California 93257 —
Not listed Redondo Beach California 90272 —
Not listed San Diego California 92123 —
Not listed San Francisco California 94115 —
Not listed Santa Barbara California 93105 —
Not listed Soquel California 95073 —
Not listed Vista California 92081 —
Not listed New London Connecticut 06320 —
Not listed Newark Delaware 19718 —
Not listed Fort Lauderdale Florida 33308 —
Not listed Fort Lauderdale Florida 33316 —
Not listed Gainsville Florida 32605 —
Not listed Jacksonville Florida 32209 —
Not listed Lake Worth Florida 33461 —
Not listed Orlando Florida 32804 —
Not listed West Palm Beach Florida 33401 —
Not listed Lawrenceville Georgia 30045 —
Not listed Macon Georgia 31201 —
Not listed Marietta Georgia 30060 —
Not listed Roswell Georgia 30076 —
Not listed Centralia Illinois 62801 —
Not listed Chicago Illinois 60640 —
Not listed Peoria Illinois 61615 —
Not listed Skokie Illinois 66077 —
Not listed Fort Wayne Indiana 46815 —
Not listed New Albany Indiana 47150 —
Not listed Danville Kentucky 40422 —
Not listed Hazard Kentucky 41701 —
Not listed Lexington Kentucky 40503 —
Not listed Lafayette Louisiana 70503 —
Not listed Shreveport Louisiana 71101 —
Not listed Annapolis Maryland 21401 —
Not listed Baltimore Maryland 21201 —
Not listed Saint Joseph Michigan 49085 —
Not listed Southfield Michigan 48076 —
Not listed St Louis Missouri 63110 —
Not listed St Louis Missouri 63141 —
Not listed Billings Montana 59101 —
Not listed Hackensack New Jersey 07601 —
Not listed Nyack New York 10960 —
Not listed Utica New York 13502 —
Not listed Chapel Hill North Carolina 27599 —
Not listed Charlotte North Carolina 28203 —
Not listed Charlotte North Carolina 28204 —
Not listed Greenville North Carolina 27834 —
Not listed Raleigh North Carolina 27609 —
Not listed Wilmington North Carolina 28401 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Bismarck North Dakota 58501 —
Not listed Cincinnati Ohio 45267 —
Not listed Cleveland Ohio 44109 —
Not listed Cleveland Ohio 44195 —
Not listed Worthington Ohio 43085 —
Not listed Dunmore Pennsylvania 18512 —
Not listed Hershey Pennsylvania 17033 —
Not listed Kingston Pennsylvania 18704 —
Not listed Kttaning Pennsylvania 16201 —
Not listed Philadelphia Pennsylvania 19106 —
Not listed Philadelphia Pennsylvania 19115 —
Not listed Philadelphia Pennsylvania 19146 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Charleston South Carolina 29403 —
Not listed Charleston South Carolina 29425 —
Not listed Greenville South Carolina 29615 —
Not listed Nashville Tennessee 37205 —
Not listed Dallas Texas 75390 —
Not listed Fort Worth Texas 76104 —
Not listed Richardson Texas 75082 —
Not listed Abingdon Virginia 24211 —
Not listed Arlington Virginia 22205 —
Not listed Kirkland Washington 98034 —
Not listed Spokane Washington 99202 —
Not listed Huntington West Virginia 25701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00081796, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2008 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00081796 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →